Open Label Rollover Study of Valbenazine for the treatment of HD
Clinical Trial Grant
Administered By
Neurology, Movement Disorders
Awarded By
Neurocrine Biosciences, Inc.
Start Date
August 25, 2020
End Date
December 31, 2024
Administered By
Neurology, Movement Disorders
Awarded By
Neurocrine Biosciences, Inc.
Start Date
August 25, 2020
End Date
December 31, 2024